Clinical support services for the research efforts of the ninds, stroke branch
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00045
- Awardee
-
Medstar Health Research Institute Inc. UEI KL1DMVY1MZM8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,570,703
Award facts
- Opportunity
-
- Clinical Support Services for the Research Efforts of the NINDS, Stroke Branch Pre-Solicitation · 75N95024R00106 · Posted Jul 17, 2024
- Contract value 48% obligated
-
- $2,570,703.00 Current, with exercised options
- $5,359,557.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 622110 General Medical and Surgical Hospitals
- PSC
- Q999 Medical- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- UNIVERSITY PA, MD 20782, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,085,643 | |
| Exercise an Option | $1,062,752 | |
| Original award | $422,308 |
About this award
The National Institute on Drug Abuse, operating under the National Institutes of Health within the Department of Health and Human Services, awarded a definitive cost-reimbursement contract valued at approximately $5.4 million to Medstar Health Research Institute Inc. on September 28, 2024. The contract, with an ultimate completion date of September 27, 2029, provides clinical support services for the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Branch research efforts. The work will be performed in Chillum, Maryland, and encompasses 24/7 stroke care, advanced imaging services including MRI and CT scanning, laboratory testing, radiological support, and nurse coordinator services to facilitate NINDS research on magnetic resonance imaging applications for acute stroke and traumatic brain injury patients as well as the development of acute stroke therapies. The award carries no socioeconomic set-aside designation.
Medstar Health Research Institute Inc., a non-profit healthcare research organization and subsidiary of Medstar Health Inc., was selected through competitive procurement based on its qualification as a Primary or Comprehensive Stroke Center with access to advanced imaging capabilities including a 3-Tesla MRI scanner. The organization's extensive experience supporting federal health research initiatives through prior contracts and grants with the National Institutes of Health, including work with the National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases, positions it well to deliver the specialized clinical and research coordination services required under this contract vehicle.
Quick answers
Who was awarded contract 75N95024C00045?
75N95024C00045 was awarded to Medstar Health Research Institute Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2024.
How much is contract 75N95024C00045 worth?
The government has obligated $2,570,703 on 75N95024C00045. Its potential value, with all options, is $5,359,557.
Was contract 75N95024C00045 competed?
The extent of competition for 75N95024C00045 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award